Opinion|Videos|May 15, 2024

Key Findings from MAJIC-PV

A comprehensive overview of key findings from the MAJIC-PV trial investigating ruxolitinib in patients with polycythemia vera, highlighting efficacy and symptom improvement.


Latest CME